CompletedNCT00136825
N-acetylcysteine safety and cue responses in cocaine dependence
About this title
Read the official source — NCT00136825Medication studyAges 18–45United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 45 years.
- Listed locations
- CharlestonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateMarch 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 17
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT00136825
- Official title
Show the full official title
N-acetylcysteine as Treatment in Cocaine Addiction
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Charleston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.
Did this study involve medication?
Yes. The study involved medication, including N-Acetylcysteine and Placebo.
Who was this study for?
Listed age limits: 18 years to 45 years.
